Ligand validation:4JZK

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4JZK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4JZK_AMP_A_302	79%	41%	0.115	0.962	0.85	1.42	1	2	1	0	100%	1
4JZK_AMP_B_302	69%	49%	0.108	0.922	0.75	1.19	-	2	2	0	100%	1
8RJ6_AMP_A_303	75%	50%	0.101	0.933	1.16	0.79	2	-	0	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1
3CLR_AMP_C_1262	100%	41%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.